Novavax Inc at Jefferies London Healthcare Conference Transcript
Welcome, everyone. This is Roger Song, one of the senior biotech equity analysts at Jefferies in the U.S. Next presenter company is Novavax, and welcome John, CCO and the CBO and the Filip, CMO. Yes, in the next 25, 35 -- 30 minutes, we have this fireside chat to talk about Novavax, the platform, the pipeline, very exciting launch for the COVID vaccine. Let's get to it. All right?
Questions & Answers
So maybe let's get started. We know Novavax is a vaccine company, long-standing vaccine company. What are the key technology you have? And why we -- your vaccine can be differentiated from other vaccines?
So maybe I'll start off with that. So we have one core technology that we deploy against all of our target diseases. And it's a recombinant protein that's made in baculovirus. And that's important
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
